Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension

Class:IdLiteratureReference:9615163
_displayNameAntihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension
_timestamp2018-07-31 09:27:11
author[Person:9615180] Nilsson, Peter
created[InstanceEdit:9615129] Jassal, Bijay, 2018-07-31
journalBlood Press Suppl
pages25-30
pubMedIdentifier18046976
titleAntihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension
volume2
year2007
(literatureReference)[Summation:9614951] Angiotensin-converting enzyme (ACE) is a central component o...
[ChemicalDrug:9614922] zofenoprilat [extracellular region]
[ChemicalDrug:9619042] zofenoprilat [endoplasmic reticulum lumen]
[Change default viewing format]
No pathways have been reviewed or authored by Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension (9615163)